Showing results (91-100 of 144) with videos related to
Sort By:
Pageof 15
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|November 1, 2022
TCR CDR3-antigen chemical complementarity associated with poor ovarian cancer outcomes: A vestigial immune response to early cancer antigens?Vayda R Barker, Mallika Varkhedi, Dhruv N Patel, et al.Neuro-Oncology Advances|February 2, 2026
T-cell receptor sequencing for detection of Epstein-Barr and cytomegalovirus-specific immune responses in glioma patients: An exploratory studyAnna E Coghill, Nathan Van Bibber, Sean Yoder, et al.International Journal of Immunogenetics|November 27, 2018
TRB-J1 usage, in combination with the HLA-A*01:01 allele, represents an apparent survival advantage for uterine corpus endometrial carcinoma: Comparisons with microscopic assessments of lymphocyte infiltratesKendall R Clark, Wei Lue Tong, Blake M Callahan, et al.Journal of Pediatric Urology|October 23, 2024
Stratification of Wilms tumor patients using physicochemical properties of the adaptive immune receptor polypeptides, IGL and TRGDavid P Adams, Etienne C Gozlan, Nikhila Medikonda, et al.Journal of Molecular Neuroscience : MN|July 27, 2022
Tumor Resident, B-Cell Receptor Chemical Characteristics Associated with Better Overall Survival for NeuroblastomaDorottya B Kacsoh, Dhruv N Patel, Monica Hsiang, et al.Computers in Biology and Medicine|December 7, 2024
A computational approach to matching multiple sclerosis-related, IGH CDR3s with a MBP epitopeJustin M Cole, Jacob T Treanor, Cassondra M Lyman, et al.International Journal of Immunogenetics|July 23, 2021
A comparison of immune receptor recombination databases sourced from tumour exome or RNAseq files: Verifications of immunological distinctions between primary and metastatic melanomaDhruv N Patel, Michelle Yeagley, Juan F Arturo, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|April 26, 2019
Potential MMP2-mediated availability of HLA binding, mutant ECM peptides reflects better melanoma survival rates and greater T-cell infiltratesSaif Zaman, Boris I Chobrutskiy, Jay S Patel, et al.Clinical Colorectal Cancer|August 22, 2024
Adaptive Immune Receptor Distinctions Along the Colorectal Polyp-Tumor TimelapseTaha I Huda, Diep Nguyen, Arpan Sahoo, et al.Journal of Biomolecular Structure & Dynamics|May 11, 2022
Chemical complementarity between immune receptor CDR3s and candidate cancer antigens correlating with reduced survival: evidence for outcome mitigation with corticosteroid treatmentsAnishaa R Patel, Dhruv N Patel, Yaping N Tu, et al.Pageof 15